• 1
    National Center for Health Statistics. Health, United States, 2007. With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics, 2007.
  • 2
    Cherry D, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 Summary. Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics. 2007;387.
  • 3
    Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007;370:591603.
  • 4
    Ong KL, Cheung BMY, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007; 49:6975.
  • 5
    Moser M, Franklin SS. Hypertension management: results of a new national survey for the Hypertension Education Foundation: Harris Interactive. J Clin Hypertens. 2007; 9:316323.
  • 6
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199206.
  • 7
    Healthy People 2010 Objectives. Accessed November 19, 2008.
  • 8
    Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:12961310.
  • 9
    Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:3137.
  • 10
    Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed. 2007;9:58.
  • 11
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487497.
  • 12
    Vinker S, Alkalay A, Hoffman RD, et al. Long-term adherence to antihypertensive therapy: a survey in four primary care clinics. Expert Opin Pharmacother. 2008;9:12711277.
  • 13
    Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens. 2008;10:130139.
  • 14
    Kim MT, Han H-R, Hill MN, et al. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med. 2003;26:2431.
  • 15
    Stuart B, Zacker C. Who bears the burden of Medicaid drug copayment policies? Health Aff. 1999;18:201212.
  • 16
    Wilson J, Axelsen K, Tang S. Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medications. Am J Manag Care. 2005;11(Spec No):SP27SP34.
  • 17
    Muszbek N, Brixner D, Benedict A, et al. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int J Clin Pract. 2008;62:338351.
  • 18
    Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:11141117.
  • 19
    Bosworth HB, Powers B, Grubber JM, et al. Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med. 2008;23:692698.
  • 20
    Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239245.
  • 21
    Pollard W. Use of consumer panel survey data for public health communication planning: an evaluation of survey results. 2002 Proceedings of the Section on Health Policy Statistics. American Statistical Association; 2002:27202724.